HOME     CONTACT     BACK

 
 
 
THE PHARMA REVIEW OCTOBER 2006

INDIA - Emerging Clinical Research Hub

Cygnus Business Consulting & Research

Abstract: Clinical Research is one of the major steps in the development of new drugs to address diseases. All drugs should be undergoing different phases of clinical trials to safeguard mankind. The pharmaceutical industry invests between 10 to 20% of annual sales revenues in research and development, which is far higher than other research-based sectors. The entire process from the development of molecule to release as drug in the market will take nearly 10-20 years of time and nearly US$500-800 million expenditure. There is nearly 10 fold increase in cost since the mid seventies. The global pharmaceutical market is estimated at US$427 billion and Research & Development cost is estimated at US$ 60-65 billion annually. Clinical trials involve almost 70% of time and money of new drug development. Even after successful completion of all these steps, some times due to severe side effects the drug has to be withdrawn from the market. The entire process is completely dependent upon the team of dedicated professionals from different fields and their coordination.

 
Go to Content Index Page

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com

 
 
 

 Copyright 2008. KONGPOSH PUBLICATIONS Pvt. Ltd.